Cardinal Health, Inc. (CAH)

In the past six months, Cardinal Health's stock has experienced positive momentum, surging 65.3% over the past 52 weeks and 35.6% in the past six months. Key events include exceeding Q1 and Q2 FY2026 earnings expectations, raising full-year guidance due to strong demand for specialty drugs, completing share repurchases, and strategic acquisitions.

There is evidence of demand seasonality for certain Cardinal Health products, particularly respiratory diagnostics ahead of the seasonal flu, strep, and RSV season. The company launched an inventory reserve program to help laboratories and health systems more accurately pre-order these diagnostics.

Cardinal Health, Inc. is an American multinational healthcare services and products company headquartered in Dublin, Ohio, specializing in the distribution of pharmaceuticals and medical products, serving over 100,000 locations, including hospitals, healthcare systems, pharmacies, and physician offices. The company's business is divided into Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. Major products and services include pharmaceutical distribution, medical and surgical products, radiopharmacies, supply chain services, pharmacy management services, repackaging, and other solutions like at-Home Solutions and OptiFreight® Logistics.

Cardinal Health, Inc. operates globally, with services and products reaching customers in the United States and internationally, maintaining a broad network of offices and facilities across the globe.

Information specifically detailing events that have affected Cardinal Health, Inc.'s brand reputation in the past year is not explicitly available in the provided search results. Historically, Cardinal Health has been involved in opioid lawsuits, but this is not a recent event within the specified timeframe.

Cardinal Health, Inc. has a diverse ownership structure, with institutional investors holding a significant portion of the company's stock, approximately 83%. Major institutional owners include BlackRock, Inc., Vanguard Group Inc, and State Street Corp. Insiders own approximately 0.24% of the stock, while public companies and individual investors hold around 28.00% to 48.41%.